X-spine has been cleared by the FDA to market its Silex system for sacroiliac joint fusion. The device, which is being showcased at an orthopedic meeting this week in Chicago, is implanted using less-invasive incisions and is designed to stabilize the SI joint even in patients who have received failed treatments.
X-spine's sacroiliac joint fusion device wins FDA nod
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||